{
  "symbol": "ASMB",
  "company_name": "Assembly Biosciences",
  "ir_website": "https://www.assemblybio.com/investors/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Press Releases",
          "url": "https://investor.assemblybio.com/press-releases",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/logo.svg) ](http://www.assemblybio.com/) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search.svg) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search_wht.svg)\n\nOn the\n\n![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/investors.jpg)\n\n  * [Press Releases](/press-releases)\n  * [Events & Presentations](/events-presentations)\n\n\n\n##  Press Releases \n\nYear None202420232022202120202019201820172016201520142013201220112010\n\n2024\n\nDate| Title and Summary| Additional Formats  \n---|---|---  \nNov 07, 2024  |  [Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates](/news-releases/news-release-details/assembly-biosciences-reports-third-quarter-2024-financial) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-reports-third-quarter-2024-financial) [PDF Version](/node/13491/pdf)  \nSep 23, 2024  |  [Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366](/news-releases/news-release-details/assembly-biosciences-reports-positive-interim-phase-1a-results) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-reports-positive-interim-phase-1a-results) [PDF Version](/node/13456/pdf)  \nAug 08, 2024  |  [Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates](/news-releases/news-release-details/assembly-biosciences-reports-second-quarter-2024-financial) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-reports-second-quarter-2024-financial) [PDF Version](/node/13421/pdf)  \nJul 15, 2024  |  [Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop](/news-releases/news-release-details/assembly-biosciences-presents-new-preclinical-data-highlighting) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-presents-new-preclinical-data-highlighting) [PDF Version](/node/13406/pdf)  \nJun 18, 2024  |  [Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection](/news-releases/news-release-details/assembly-biosciences-doses-first-participant-phase-1b-clinical) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-doses-first-participant-phase-1b-clinical) [PDF Version](/node/13336/pdf)  \nJun 17, 2024  |  [Assembly Biosciences Announces $12.6 Million in Equity Financings](/news-releases/news-release-details/assembly-biosciences-announces-126-million-equity-financings) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-announces-126-million-equity-financings) [PDF Version](/node/13326/pdf)  \nJun 10, 2024  |  [Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366](/news-releases/news-release-details/assembly-biosciences-doses-first-participant-phase-1ab-clinical) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-doses-first-participant-phase-1ab-clinical) [PDF Version](/node/13316/pdf)  \nJun 05, 2024  |  [Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024](/news-releases/news-release-details/assembly-biosciences-presents-new-data-highlighting-hepatitis-d) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-presents-new-data-highlighting-hepatitis-d) [PDF Version](/node/13311/pdf)  \nMay 22, 2024  |  [Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024](/news-releases/news-release-details/assembly-biosciences-present-data-upcoming-international-0) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-present-data-upcoming-international-0) [PDF Version](/node/13226/pdf)  \nMay 08, 2024  |  [Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights](/news-releases/news-release-details/assembly-biosciences-reports-first-quarter-2024-financial) |  [View HTML](/news-releases/news-release-details/assembly-biosciences-reports-first-quarter-2024-financial) [PDF Version](/node/13196/pdf)  \n  \nShareholder Tools [Print](#print) [Email Alerts](/email-alerts) [RSS News Feeds](/rss-news-feeds)\n\nSearch Investors \n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "Financials & Filings",
          "url": "https://investor.assemblybio.com/financial-information",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/logo.svg) ](http://www.assemblybio.com/) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search.svg) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search_wht.svg)\n\nOn the\n\n![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/investors.jpg)\n\n  * [Financials & Filings](/financial-information)\n  * [Quarterly Results](/financial-information/quarterly-results)\n  * [SEC Filings](/financial-information/sec-filings)\n  * [Annual Reports](/financial-information/annual-reports)\n\n\n\n##  Financials & Filings \n\n## Annual Reports\n\nDocuments  \n---  \n[2023 Annual Report 3.29 MB](/static-files/d03503fe-2ab6-42f0-9923-119f7e3cd286)  \n[2022 Annual Report 3.7 MB](/static-files/e7c6185f-bc63-411c-9936-6d5613ffced2)  \n  \n## Proxy Statements\n\n[Filing date ](?field_nir_sec_form_group_target_id%5B491%5D=491&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | [Form](?field_nir_sec_form_group_target_id%5B491%5D=491&order=field_nir_sec_form&sort=asc \"sort by Form\") | View  \n---|---|---  \nApr 17, 2024 | [DEF 14A](/sec-filings/sec-filing/def-14a/0000950170-24-045105) |  [0000950170-24-045105.pdf](/static-files/15fb78cf-5c03-4ad1-b273-bd82e829070a) [0000950170-24-045105.rtf](/static-files/3df61a94-39b9-4f2a-b1d9-c291a234f78b) [0000950170-24-045105.xls](/static-files/b0b270dc-61d1-45c1-bc76-4dd8a04abfde) [EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/def-14a/0000950170-24-045105) [View HTML](/node/13171/html)  \nApr 17, 2024 | [DEFA14A](/sec-filings/sec-filing/defa14a/0000950170-24-045122) |  [0000950170-24-045122.pdf](/static-files/e176f2c0-e89d-41cc-aee1-759d49665cac) [0000950170-24-045122.rtf](/static-files/1dbe5a43-0409-4835-b2ae-92e43151512c) [0000950170-24-045122.xls](/static-files/85691ee1-1d56-4fb3-91d3-77d68ef63953) [View HTML](/node/13176/html)  \n  \n## Form 10-K\n\n[Filing date ](?field_nir_sec_form_group_target_id_1%5B611%5D=611&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | View  \n---|---  \nMar 28, 2024 |  [0000950170-24-038057.pdf](/static-files/390fc138-a8c4-48dc-acc2-137b9b1a75a7) [0000950170-24-038057.rtf](/static-files/8e7731e5-3ff1-49bf-8e24-c662df9b8d6f) [0000950170-24-038057.xls](/static-files/8c8bb4fe-0350-47a1-8ca6-a07818b44159) [View HTML](/node/13131/html)[EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-k/0000950170-24-038057)  \nMar 22, 2023 |  [0000950170-23-009184.pdf](/static-files/4e5ee582-9955-4d24-bfba-780e403db302) [0000950170-23-009184.rtf](/static-files/1c05a655-537f-4e20-ae36-afcdd2582252) [0000950170-23-009184.xls](/static-files/83260042-7448-4571-b10f-ceb6a199c50f) [View HTML](/node/12416/html)[EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-k/0000950170-23-009184)  \n  \n## Form 10-Q\n\n[Filing date ](?field_nir_sec_form_group_target_id%5B496%5D=496&order=field_nir_sec_date_filed&sort=asc \"sort by Filing date\") | View  \n---|---  \nNov 7, 2024 |  [0000950170-24-123402.pdf](/static-files/8123680e-d1a2-44b6-a066-2b871f28f064) [0000950170-24-123402.rtf](/static-files/a9bdb27c-2c23-45c3-b68d-fba0e2e18f77) [0000950170-24-123402.xls](/static-files/19ff3995-26b5-4f70-9605-1c23d8d9dd6a) [View HTML](/node/13511/html)[EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0000950170-24-123402)  \nAug 8, 2024 |  [0000950170-24-093998.pdf](/static-files/4440d358-2127-407b-8e7d-95a2b445c0ff) [0000950170-24-093998.rtf](/static-files/93127f26-a8e9-4bc0-8211-e0c4582c7de5) [0000950170-24-093998.xls](/static-files/7e4dd04b-1516-4b8a-8952-89dce165dc12) [View HTML](/node/13441/html)[EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA](/sec-filings/sec-filing/10-q/0000950170-24-093998)  \n  \nShareholder Tools [Print](#print) [Email Alerts](/email-alerts) [RSS News Feeds](/rss-news-feeds)\n\nSearch Investors \n"
        }
      ]
    },
    {
      "section_name": "Events & Presentations",
      "links": [
        {
          "title": "Events & Presentations",
          "url": "https://investor.assemblybio.com/events-presentations",
          "content": "[ Skip to main navigation ](#main-menu)\n\n[ ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/logo.svg) ](http://www.assemblybio.com/) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search.svg) ![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/search_wht.svg)\n\nOn the\n\n![](/sites/g/files/knoqqb91536/themes/site/nir_pid1491/redesign/_img/investors.jpg)\n\n  * [Press Releases](/press-releases)\n  * [Events & Presentations](/events-presentations)\n\n\n\n##  Events & Presentations \n\n## Upcoming Events\n\nMore events are coming soon.  \n---  \n  \n## Presentations\n\nDocuments  \n---  \n[Assembly Biosciences Corporate Presentation ](/static-files/d9d364f1-6b39-48d6-8e13-22a248312832)  \n  \n## Archived Events\n\nDate| Event Details| Remind Me  \n---|---|---  \nJul 13 - Jul 17, 2024  |  [48th Annual International Herpesvirus Workshop (IHW)](/events/event-details/48th-annual-international-herpesvirus-workshop-ihw)  \nJun 5 - Jun 8, 2024  |  [EASL 2024 – The International Liver Congress](/events/event-details/easl-2024-international-liver-congress)  \nNov 10 - Nov 14, 2023  |  [AASLD – The Liver Meeting® 2023](/events/event-details/aasld-liver-meetingr-2023)  \n  \nShareholder Tools [Print](#print) [Email Alerts](/email-alerts) [RSS News Feeds](/rss-news-feeds)\n\nSearch Investors \n"
        }
      ]
    }
  ]
}